0001104659-20-022138.txt : 20200214 0001104659-20-022138.hdr.sgml : 20200214 20200214212852 ACCESSION NUMBER: 0001104659-20-022138 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200210 FILED AS OF DATE: 20200214 DATE AS OF CHANGE: 20200214 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Gionco David CENTRAL INDEX KEY: 0001456864 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35619 FILM NUMBER: 20623082 MAIL ADDRESS: STREET 1: 9 HOWELL DRIVE CITY: FAR HILLS STATE: NJ ZIP: 07931 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: STEMLINE THERAPEUTICS INC CENTRAL INDEX KEY: 0001264587 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 450522567 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 750 LEXINGTON AVENUE STREET 2: ELEVENTH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: 646-502-2311 MAIL ADDRESS: STREET 1: 750 LEXINGTON AVENUE CITY: NEW YORK STATE: NY ZIP: 10022 4 1 a4.xml 4 X0306 4 2020-02-10 0 0001264587 STEMLINE THERAPEUTICS INC STML 0001456864 Gionco David C/O STEMLINE THERAPEUTICS, INC. 750 LEXINGTON AVENUE, ELEVENTH FLOOR NEW YORK NY 10022 0 1 0 0 Chief Accounting Officer Common Stock 2020-02-10 4 A 0 107317 0 A 342738 D The 107,317 shares will vest in three installments as follows: 35,773 shares will vest on January 20, 2021; 35,772 shares will vest on February 16, 2022, and 35,772 shares will vest on March 29, 2023. Of the shares listed, 287,719 shares are restricted stock. /s/ David Gionco 2020-02-14